Concepedia
Statistics
Publications
9
Citations
5.7K
H-Index
Active since
1991
Affiliations
Pfizer (United States)(Current)
Harvard University
Inflammation Research Foundation
Sanofi (United States)
Michael Bowman is an author at Pfizer (United States) specializing in medicine, cell biology, and autoimmunity.
Top concepts
MedicineCell BiologyImmunologyAutoimmunityInflammationPharmacologyAutoimmune DiseaseSignal TransductionMolecular PhysiologyAllergy
Publications per year
1991–2023
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
Gordon J. Freeman, Andrew J. Long, Yoshiko Iwai et al. · The Journal of Experimental Medicine · 2000 · 5.2K citations · Full text
Subsets of ILC3−ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues
Marina Cella, Ramya Gamini, Cristiane Sécca et al. · Nature Immunology · 2019 · 189 citations · Full text
Inflammation, Ilc3−ilc1-like Cells, Autoimmune Disease +10
Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation
Michael J. Primiano, Bruce A. Lefker, Michael Bowman et al. · The Journal of Immunology · 2016 · 172 citations
Human Alveolar Macrophage Gene Responses to <i>Mycobacterium tuberculosis</i> Strains H37Ra and H37Rv
Richard F. Silver, Jessica Walrath, Hung Lee et al. · American Journal of Respiratory Cell and Molecular Biology · 2008 · 64 citations · Full text
The CD4 molecule is not always required for the T cell response to bacterial enterotoxins.
Rafick‐Pierre Sékaly, G Croteau, Michael Bowman et al. · The Journal of Experimental Medicine · 1991 · 20 citations · Full text
Cd4+ Cells, Adaptive Immune System, T-regulatory Cell +23
1–5 of 9